Impact of Digitalization in strengthening the regulatory functions of NAFDAC: Opportunities and Challenges for other National Regulatory Authorities
Keywords:
NAFDAC, DIGITALIZATION, WHO, innovation, REGULATORYAbstract
The digitalization stride employed by the National Agency for Food and Drug Administration and Control (NAFDAC) as a National Regulatory Authority (NRA) to strengthen its regulatory functions represents a paradigmatic shift from a primordial method to digital innovation and automation of its regulatory processes. This review X-rays the impact of digitalization and automation of regulatory functions in NAFDAC and the significant contribution of digital innovation to the landmark achievements of the Agency as a WHO-ML3 NRA and one of the NRAs in the world with a Prequalified Laboratory by the World Health Organization. This synopsis also examines the technological components of digitalization deployed by NAFDAC and the inherent opportunities. Notably, some of the gains from digital innovation include promoting regulatory efficiency, data integrity, improving efficient management of human resources, minimizing the prevalence of Substandard and Falsified Regulated Products, improving real-time access to regulatory information, enhancing transparency, and improving public confidence. In other ways, digitalization strengthens regulatory collaborations between the Agency and other NRAs around the globe. The discourse further evaluates the role of digitalization in the assessment of regulatory functions of NRAs for Global Benchmarking Tools and Maturity levels by the World Health Organization and summarizes challenges in the digitalization of regulatory functions. Thus, embracing digital innovations, and modern technologies in regulatory processes is a transformative and innovative strategy to promote regulatory efficiency, data integrity, and effectiveness in strengthening the regulatory functions of NRAs.
References
National Agency for Food and Drug Administration and Control page. https://www.nafdac.gov.ng/.
WHO Certifies NAFDAC as ML3 Regulatory Authority. https://www.nafdac.gov.ng/who-certifies-nafdac-as-ml3-regulatory-authority/.
List of National Regulatory Authorities (NRAs) operating at maturity level 3 (ML3) and maturity level 4 (ML4). https://www.who.int/publications/m/item/list-of-nras-operating-at-ml3-and-ml4.
WHO Global Benchmarking & Quality Management Program. https://www.nafdac.gov.ng/about-nafdac/nafdac-programs/who-global-benchmarking-quality-management-program/.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 SABITU OLASUPO, Mojisola Adeyeye, Abayomi Akinyemi, John Kayode, Uche Sonny-Afoekelu
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
By submitting content to the Journal of Regulatory Science (JRS), authors agree to the following terms:
- Authors retain copyright and grant the JRS the right of first publication. Authors retain patent, trademark, and other intellectual property rights (including research data) and grant third parties the right to use, reproduce, and share the article according to the Creative Commons — Attribution-NonCommercial 4.0 International — CC BY-NC 4.0 license agreement. The JRS is an open access journal and, as a result, articles are free to use with proper acknowledgment of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.
- If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.
- The publication of the submission has been approved by all co-authors and responsible authorities at the institute or organization where the work has been carried out.
- Copyright has not been breached in seeking publication of the submission.